Golden Lee Scott 4

What Happened Golden Lee Scott, EVP & Chief Medical Officer of PTC Therapeutics (PTCT), disposed of 2,484 shares in an open‑market sale on February 18, 2026 at $69.36 per share, for proceeds of $172,290. The sale is recorded as an S (sale) transaction.

Key Details

• Transaction date and price: 2,484 shares sold on 2026-02-18 at $69.36 per share (total $172,290).
• Filing date: Form 4 filed 2026-02-20 — appears timely (within the two-business-day reporting window).
• Shares owned after transaction: Not specified in the excerpt provided.
• Footnote (F1): The shares sold were automatically sold pursuant to an irrevocable “sell-to-cover” election to satisfy tax withholding obligations related to RSU vesting — specifically, vesting of 5,000 RSUs from a Feb 15, 2024 grant of 20,000 RSUs and 1,300 RSUs from a Feb 15, 2024 grant of 2,600 RSUs.
• Transaction code: S = Sale; footnote indicates tax-withholding (F) action.

Context This sale was a routine sell-to-cover tied to the vesting of restricted stock units (RSUs) to meet tax withholding obligations, rather than a discretionary open-market trade for investment purposes. Such automatic withholding sales are common following RSU vesting and do not necessarily indicate the insider’s view on the company's prospects.